Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/656033


The North America Biotechnology Sectors : A Company and Industry Analysis (February 2007)


Description: This report looks at the biotechnology industry in the United States and Canada
Current Environment - Key Points
- Biotech had an improved final quarter in 2006 compared to the third quarter
The NASDAQ Biotech Index was up by nearly 7% over the six months to the end of the year
The Amex Biotech Index grew 12.8% over the same period
- The Canadian biotech sector, which faltered in the second quarter of 2006, continued to decline in the third quarter but rebounded in October and November as falling oil prices pushed stocks higher
- There was a surge in the values of biotech buyouts over the past six months
A Mergent analysis showed that in the second half of 2006, there were about 17 biotech M&As in the US worth an estimated US$8.80 billion
The amount was more than double the US$3.3 billion recorded by 32 companies in the first half
- In the second half of 2006 the Canadian biotech sector saw six biotech M&As, with a total value of US$624.5 million
- In the US, five biotech companies completed their IPOs in the second half of 2006
The US$299.5 million raised from IPOs was down 29% from the US$423.3 million raised in the first half of 2006
Only one biotech company managed to get listed in Canada in the second half of 2006

Industry Profile - Key Points
- In 2006, industrial biotech was given a boost in the US, mainly due to breakthroughs in the production of bioethanol and President Bush's Advanced Energy Initiative (AEI)
- On December 12, 2006, the Senate passed legislation that aims to help create cellulosic biomass ethanol plants
- The Securities and Exchange Commission (SEC) announced plans to ease auditing standards for small, publicly traded companies
- In the US, the biotech sector enjoyed greater finance levels over the past six months
A Mergent Analysis showed that in the second half of 2006, 35 biotech companies raised US$1,018 million in venture capital
- In October 2006, the Canadian Biotechnology Advisory Committee (CBAC) published a report in an effort to review the existing Canadian Biotechnology Strategy
- In December 2006, the Canadian Federal Government announced regulations to require 5% renewable content in gasoline by 2010 and a 2% renewable content in diesel and home heating fuel by no later than 2012
Market Trends and Outlook - Key Points
- With some biologic drugs costing up to US$100,000 a year for rare disorders, generics offer lower costs
Currently, no regulatory mechanism exists in the US to approve substitute versions of biotech drugs
Democrat control of Congress is expected to lead to legislation allowing generic versions of popular biotech drugs
- A survey by strategic management and technology consulting firm Booz Allen Hamilton of top global companies found that three quarters of R&D sites planned in 2007 will go to India and China
- Organizations, institutes and regulators around the world are increasingly forming international links as a way to strengthen their biotech industries
- On December 6, 2006, the National Research Council of Canada signed a Memorandum of Understanding (MOU) with the Government of India to extend scientific collaboration in the field of biotech


Contents: Current Environment - US
- Sector Overview
- Sector Performance
- Leading Companies
- Mergers, Acquisitions and
Alliances
- Initial Public Offerings
Current Environment - Canada
- Sector Overview
- Sector Performance
- Leading Companies
- Mergers, Acquisitions and
Alliances
- Initial Public Offerings
Industry Profile - US
- Industry Size and Value
- Industry Focus
- Sector Investment
- Government Investment
- Policy and Regulatory
Environment
Industry Profile - Canada
- Industry Size and Value
- Industry Focus
- Sector Investment
- Government Investment
- Policy and Regulatory
Environment
Market Trends and Outlook
-
US
- Biotech Drug Prices Widen the
Path for Biogenerics
- Concern Over Offshoring Grows
- US Ethanol Production On The
Rise
- Market Outlook
Market Trends and Outlook -
Canada
- The Interest in Renewable Fuels
Grows
- Increasing International
Cooperation in Biotech
- Market Outlook
Currency Conversion Table
The Scope of This Report
Key References
Comparative Data
Reports Coverage




Ordering: Order Online - visit http://www.researchandmarkets.com/reports/656033

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 29/11/2009 13:17:08
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
The North America Biotechnology Sectors : A Company and Industry Analysis (February 2007)
Web Address:
http://www.researchandmarkets.com/reports/656033
Office Code:
OC8HJNPOUMUXU

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €200.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 29/11/2009 13:17:08

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)